The FDA has given approval to Gimoti (metoclopramide, Evoke Pharma), the first nasally administered medication for the treatment of adults with symptoms of recurrent diabetic gastroparesis.
FDA Approves Single-Use TNE System From EvoEndo
EvoEndo announced that it received FDA 510(k) regulatory device clearance of the EvoEndo Single-Use Endoscopy System for children and adults.
MARCH 31, 2022
FDA Approves Rinvoq for Treatment of Ulcerative Colitis
The FDA approved upadacitinib (Rinvoq, AbbVie) for the treatment of adults with moderately to severely active ulcerative colitis (UC) in cases in which intolerance or poor responses to one or more tumor necrosis factor blockers were recorded.
MARCH 22, 2022
FDA Clears New Single-Use Scope From Ambu
The FDA has given 510(k) regulatory clearance to a new sterile, single-use scope, the first from Ambu.
